Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Importation and Transmission of SARS-CoV-2 B.1.1.529 (Omicron) Variant of Concern in Korea, November 2021Importation and Transmission of SARS-CoV-2 B.1.1.529 (Omicron) Variant of Concern in Korea, November 2021
- Other Titles
- Importation and Transmission of SARS-CoV-2 B.1.1.529 (Omicron) Variant of Concern in Korea, November 2021
- Authors
- Lee, Ji Joo; Choe, Young June; Jeong, Hyeongseop; Kim, Moonsu; Kim, Seonggon; Yoo, Hanna; Park, Kunhee; Kim, Chanhee; Choi, Sojin; Sim, JiWoo; Park, Yoojin; Huh, In Sil; Hong, Gasil; Kim, Mi Young; Song, Jin Su; Lee, Jihee; Kim, Eun-Jin; Rhee, Jee Eun; Kim, Il-Hwan; Gwack, Jin; Kim, Jungyeon; Jeon, Jin-Hwan; Lee, Wook-Gyo; Jeong, Suyeon; Kim, Jusim; Bae, Byungsik; Kim, Ja Eun; Kim, Hyeonsoo; Lee, Hye Young; Lee, Sang-Eun; Kim, Jong Mu; Park, Hanul; Yu, Mi; Choi, Jihyun; Kim, Jia; Lee, Hyeryeon; Jang, Eun-Jung; Lim, Dosang; Lee, Sangwon; Park, Young-Joon
- Issue Date
- 27-12월-2021
- Publisher
- KOREAN ACAD MEDICAL SCIENCES
- Keywords
- Coronavirus; COVID-19; SARS-CoV-2; Omicron Variant
- Citation
- JOURNAL OF KOREAN MEDICAL SCIENCE, v.36, no.50, pp.1 - 4
- Indexed
- SCIE
SCOPUS
KCI
- Journal Title
- JOURNAL OF KOREAN MEDICAL SCIENCE
- Volume
- 36
- Number
- 50
- Start Page
- 1
- End Page
- 4
- ISSN
- 1011-8934
- Abstract
- In November 2021, 14 international travel-related severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.529 (omicron) variant of concern (VOC) patients were detected in South Korea. Epidemiologic investigation revealed community transmission of the omicron VOC. A total of 80 SARS-CoV-2 omicron VOC-positive patients were identified until December 10, 2021 and 66 of them reported no relation to the international travel. There may be more transmissions with this VOC in Korea than reported.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - ETC > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.